
Wolverine (BPC-157 + TB-500)
10MG (5+5) · per vial
Purity
≥99% (HPLC), each component
Form
White lyophilised powder
About This Compound
A two-component lyophilised preparation of BPC-157 and the thymosin beta-4 fragment Ac-LKKTETQ (TB-500), 5mg of each per vial. Supplied as a single blend so both sequences can be introduced together in comparative in vitro work on angiogenic signalling and actin dynamics. Sealed under inert gas. Research use only. Not for human or veterinary use.
Compound class
Certificate of Analysis
Wolverine (BPC-157 + TB-500) 10MG (5+5)
For laboratory research use only. Not a drug, food additive, cosmetic, or dietary supplement. Not for human or veterinary consumption.
Specifications
Physical and analytical data for this compound, recorded against the tested batch. Identity and purity results are published in the Certificate of Analysis.
- Purity
- ≥99% (HPLC), each component
- Endotoxin
- <1 EU/mg (LAL)
- Appearance
- White lyophilised powder
- Solubility
- Soluble in bacteriostatic or sterile water
- Storage
- Lyophilised: −20°C, protected from light. Reconstituted: 2–8°C, use within 30 days.
